CBD of Denver has moved to acquire a Greece-based firm in the cannabis biotechnology sector known as BioCannabis. The transaction is structured as a share exchange rather than a cash purchase.
Under the proposed arrangement, the owners of the Greek company would receive shares in CBD of Denver in return for handing over control of their business. This structure allows the deal to proceed without a large upfront cash outlay.
The acquisition has not yet closed, and the companies remain separate until the share exchange is completed. The transaction is subject to the customary conditions that apply to deals of this kind.
CBD of Denver is a company operating in the cannabidiol and broader cannabis space. The firm has previously pursued growth through acquisitions and corporate transactions.
The target company is based in Greece, a country where licensed cannabis cultivation and processing have attracted international investment in recent years.
In a share exchange, the acquiring company issues its own stock to the shareholders of the company being acquired. Those shareholders then become part-owners of the combined business.
This type of deal is common when a company wants to expand into a new market or add capabilities without spending cash. It also aligns the interests of the acquired firm’s owners with the future performance of the combined company.
For CBD of Denver, the deal would add a Greece-based operation to its holdings. The acquisition would give the company a foothold in the European cannabis sector.
The companies have not disclosed the total value of the shares to be exchanged. Further details about the ownership split are expected as the transaction moves forward.
Shareholders of CBD of Denver will be watching for the final terms, since issuing new shares can affect the value of existing holdings.
The transaction is currently a proposed acquisition and has not been finalized.
CBD of Denver is expected to provide updates as the transaction progresses toward closing. Investors can look for announcements confirming when the share exchange has been completed.
If the deal closes, the Greece-based BioCannabis firm would become part of CBD of Denver’s operations.
NUG Magazine will continue to follow this story as more details about the share exchange are released.
Settlement Reached Over Unregistered Grow Site Vermont Lt. Gov. John Rodgers plans to pay a reduced fine to settle a…
NORML Responds to Times Potency Claims The National Organization for the Reform of Marijuana Laws (NORML) is pushing back against…
Clonetopia Comes Back To Richmond Clonetopia is returning to Richmond, bringing a fresh lineup of cannabis genetics to growers and…
Fourteen Measures Headed to Colorado Voters Colorado voters will decide 14 statewide ballot measures this November. The count matches 2024…
Lawsuit Filed Over Facility Odor Residents of Rock Hill are suing Proper Brands, arguing that a "skunky" smell from the…
Expert Warning On Outdated Testing Dr Georges Petitjean has warned that workplace drug testing has failed to keep pace with…
